ArticleJACC. Case reports2025
Annular Reduction by Cinching With TEER in Commissure in Conventionally Inappropriate Ring for Transcatheter Valve.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ARCTIC-T: Annular Reduction by Cinching With Transcatheter Tricuspid Edge-to-Edge Repair to Facilitate Concomitant Transcatheter Tricuspid Valve Replacement.Structural heart : the journal of the Heart Team · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAnnular reduction by cinching with transcatheter edge-to-edge repair in commissure has been described to enable valve-in-mitral annular calcification. We applied this technique to a patient with an annuloplasty ring too large to allow for treatment with available transcatheter heart valves. KEY STEPS: The key steps included the following: Gated computed tomography for measurement of annuloplasty ring, anterior mitral leaflet, and estimated neo-left ventricular outflow tract (LVOT). Transseptal left atrial access is obtained. Mitral transcatheter edge to edge repair (MTEER) is performed with preference for A3-P3 implant. Adjunctive antegrade base-to-tip laceration of the anterior mitral valve leaflet to prevent LVOT obstruction is performed if indicated. Transcatheter heart valve (THV) delivery and deployment. POTENTIAL PITFALLS: The potential pitfalls included the following: Medial deployment of the MTEER device is preferred due to the tendency of the THV to engage the lateral mitral anulus during advancement. Assessment of the neo-LVOT must consider the left ventricular septum and the anterior mitral leaflet. The degree of annular change after MTEER is unknown. TAKE-HOME MESSAGE: In the setting of a mitral annuloplasty ring larger than commercially available THVs, annular reduction by cinching with TEER in commissure in conventionally inappropriate ring for transcatheter valve may be a viable option for enabling transcatheter mitral valve replacement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.